Kestra Medical Technologies, Ltd. (KMTS) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Instruments & Supplies 行业. 公司总部位于 Kirkland, WA, 美国. 现任CEO为 Brian Webster.
KMTS 拥有 IPO日期为 2025-03-06, 300 名全职员工, 在 NASDAQ Global Select, 市值为 $1.15B.
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
